COVID-19: Public Health RE-EMERGENCY?

By Staff Reporters

***

***

The Biden administration is expected to extend the Covid-19 public health emergency once again, ensuring that federal measures expanding access to health coverage, vaccines and treatments remain in place beyond the midterm elections, three people with knowledge of the matter told POLITICO. The planned renewal follows extensive deliberations among Biden officials over the future of the emergency declaration, including some who questioned whether it was time to let the designation lapse.

Under the proposed extension, the Department of Health and Human Services would continue the declaration beyond the November elections and potentially into early 2023 — pushing the U.S. into its fourth calendar year under a Covid public health emergency. “Covid is not over. The pandemic is not over,” one senior Biden official said. “It doesn’t make sense to lift this [declaration] given what we’re seeing on the ground in terms of cases.”

READ HERE: https://www.msn.com/en-us/news/politics/biden-administration-planning-to-extend-covid-emergency-declaration/ar-AA10n7W1?cvid=b437507c87494d06803d7af868040e82

***

COMMENTS APPRECIATED

Thank You

***

DHIMC: https://www.amazon.com/Dictionary-Health-Insurance-Managed-Care/dp/0826149944/ref=sr_1_4?ie=UTF8&s=books&qid=1275315485&sr=1-4

***

The Ex-Dividend Stock Date?

WHAT IS THE “EX-DIVIDEND” STOCK DATE?

By Staff Reporters

DEFINITION: Occurs when dividends are declared by a company’s board of directors, they are payable on a certain date (“payable date”) to shareholders recorded on the company’s books as of a stated earlier date (“record date”).

Purchasers of the stock on or after the record date are not entitled to receive the recently declared dividend, so the ex-dividend date is the number of days it takes to settle a trade before the record date (currently three business days). A stock’s price on its ex-dividend date appears in the newspaper with an X beside it.

CITE: https://www.r2library.com/Resource/Title/082610254

THANK YOU
***

***

COMMENTS APPRECIATED

Thank You

***

Paxlovid and Pharmacists

FOR COVID-19 TREATMENT

By Staff Reporters

***

***

  • The FDA recently authorized pharmacists to prescribe Paxlovid to eligible patients who test positive for COVID-19. 
  • To get a Paxlovid prescription from a pharmacist, patients must be able to connect the pharmacist to a physician to discuss their medical history, or present recent kidney and liver function tests to be sure the drug is safe for them. 
  • Patients will also have to list and review all medications, including over-the-counter products they take, to be sure no dangerous interactions could occur.

***

RELATED: https://www.amazon.com/Dictionary-Health-Information-Technology-Security/dp/0826149952/ref=sr_1_5?ie=UTF8&s=books&qid=1254413315&sr=1-5

COMMENTS APPRECIATED

Thank You

***

What is a DIVIDEND ARISTOCRAT Stock?

By Dr. David Edward Marcinko MBA CMP®

SPONSOR: http://www.CertifiedMedicalPlanner.org

CMP logo

A Dividend Aristocrat is a stock that has exhibited a remarkable level of consistency, measured by the fact that only those S&P 500 companies that have increased their annual dividend for 25 straight years — or more — can be called one. The name was coined by cable TV personality and investor Jim Cramer

These companies have raised their dividends through good times and bad, including recessions, crashes, and pandemics. Being able to continue doing so is a tribute to their stability and strength. Now, the past 18 months have been a particularly difficult economic environment to operate in, and some companies were forced to slash or hold the line on their dividends as a result.

CITE: https://www.r2library.com/Resource/Title/0826102549

But others are just fine, like investment manager T. Rowe Price (NASDAQ: TROW), which increased its dividend for the 35th straight year in 2022. It is located in Baltimore Maryland not far from where I grew up. In fact, I used to play stick ball, as a kid, in the parking lot.

UPDATE: https://www.msn.com/en-us/money/markets/down-between-15-and-53-3-top-dividend-aristocrats-that-are-too-cheap-to-ignore/ar-AA10oFN9?cvid=962479fd28494731a0cd106028a00940

YOUR COMMENTS ARE APPRECIATED.

CITE: https://www.r2library.com/Resource/Title/0826102549

FOREWORD: https://healthcarefinancials.files.wordpress.com/2007/10/dr-getzen.pdf

FINANCE: https://www.amazon.com/Comprehensive-Financial-Planning-Strategies-Advisors/dp/1482240289/ref=sr_1_1?ie=UTF8&qid=1418580820&sr=8-1&keywords=david+marcinko

****

%d bloggers like this: